Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial

被引：0
|
作者：
Edwards, Christopher J. [1 ]
Aelion, Jacob A. [2 ]
Adebajo, Adewale O. [3 ]
Kivitz, Alan [4 ]
Bird, Paul [5 ]
Hu, ChiaChi [6 ]
Stevens, Randall M. [6 ]
Wells, Alvin [7 ]
机构：
[1] Southampton Univ Hosp, Southampton, Hants, England
[2] West Tennessee Res Inst, Jackson, TN USA
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Altoona Arthrit & Osteoporosis Ctr, Duncansville, PA USA
[5] Combined Rheumatol Practice, Kogarah, NSW, Australia
[6] Celgene Corp, Warren, NJ USA
[7] Rheumatol & Immunotherapy Ctr, Franklin, WI USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1572
引用
收藏
页码：S694 / S695
页数：2
相关论文
共 50 条
  • [31] Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
    Kavanaugh, Arthur
    Mease, Philip J.
    Gomez-Reino, Juan J.
    Adebajo, Adewale O.
    Wollenhaupt, Juergen
    Gladman, Dafna D.
    Hochfeld, Marla
    Teng, Lichen L.
    Schett, Georg
    Lespessailles, Eric
    Hall, Stephen
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (03) : 479 - 488
  • [32] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of a Phase 3, Randomized, Controlled Trial.
    Kavanaugh, Arthur
    Mease, Philip J.
    Gomez-Reino, Juan J.
    Adewale, Adebajo
    Wollenhaupt, Juergen
    Hu, ChiaChi
    Stevens, Randall
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4172 - 4173
  • [33] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS OF A PHASE III RANDOMIZED CONTROLLED TRIAL
    Adebajo, Adewale O.
    Kavanaugh, Arthur
    Mease, Philip
    Gomez-Reino, Juan J.
    Wollenhaupt, Jurgen
    Hu, ChiaChi
    Stevens, Randall
    [J]. RHEUMATOLOGY, 2013, 52 : 52 - 52
  • [34] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
    Kavanaugh, Arthur
    Gladman, Dafna
    Edwards, Christopher J.
    Poder, Airi
    Liote, Frederic
    Bird, Paul A.
    Schett, Georg
    McIlraith, Melissa
    Teng, Lichen
    Mease, Philip J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: results of a phase 3, randomized, controlled trial (palace 1)
    Adebajo, A. O.
    Kavanaugh, A.
    Mease, P. J.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Hu, C.
    Stevens, R.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 53 - 54
  • [36] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pharmacodynamic Results of a Phase 3, Randomized, Controlled Trial.
    Schafer, Peter
    Chen, Peng
    Fang, Lorraine
    Wang, Andrew
    Chopra, Rajesh
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S425 - S425
  • [37] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of a Phase 3, Randomized, Controlled Trial (PALACE 1)
    Adebajo, A. O.
    Kavanaugh, A.
    Mease, P. J.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Hu, C.
    Stevens, R.
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 : S123 - S123
  • [38] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENT IN FATIGUE IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS
    Kavanaugh, A.
    Gladman, D. D.
    Edwards, C. J.
    Poder, A.
    Liote, F.
    Bird, P.
    Schett, G.
    Nguyen, D.
    Teng, L.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 346 - 346
  • [39] Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 phase III, randomized, controlled trials
    Kavanaugh, Arthur
    Gladman, Dafna D.
    Edwards, Christopher J.
    Poder, Airi
    Liote, Frederic
    Bird, Paul
    Nguyen, Dianne
    Teng, Lichen
    Mease, Philip J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB47 - AB47
  • [40] WORK PRODUCTIVITY IMPROVEMENT ASSOCIATED WITH APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS RESULTS OF A PHASE 3, RANDOMIZED, CONTROLLED TRIAL
    Zhang, F.
    Tencer, T.
    Li, S.
    Strand, V
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A372 - A373
12345